Citations 3
Patient-reported Outcomes Through 12-weeks of Double-blind Rimegepant Treatment for the Prevention of Episodic Migraine in Adults with Prior Inadequate Response to Oral Preventatives (P1-15.008)
Starling, Amaal, Versijpt, Jan, Aslan, Ayşe Neslihan, Seehra, Harpreet, Ramaker, Sara Anne, McCollum, Shannin, Thiry, Alexandra, Abraham, Lucy, Fountaine, Robert, Ramirez, Luz, Versijpt, Jan J. , Sumelahti, Marja‐Liisa , Ramaker, Sara , Thiry, Alexandra, Abraham, Lucy , Fountaine, Robert J.
Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available
Rimegepant 75 mg Provides Early and Sustained Relief of Migraine With a Single Dose: Results from 3 Phase 3 Clinical Trials (2366)
Pavlović, Jelena , Tepper, Stewart J. , Stock, Elyse, Thiry, Alexandra, Conway, Charles M., Jensen, Christopher, Morris, Beth , Coric, Vladimir, Croop, Robert , Pavlovic, Jelena M. , Dodick, David W. , Friedman, Deborah I. , Newman, Lawrence C. , Lipton, Richard B.
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Rimegepant is Effective for the Acute Treatment of Migraine in Subjects Taking Concurrent Preventive Medication: Results From 3 Phase 3 Trials (2091)
Pavlović, Jelena , Stock, Elyse, Thiry, Alexandra, Conway, Charles M., Jensen, Christopher, Morris, Beth , Coric, Vladimir, Croop, Robert , Pavlovic, Jelena M. , Dodick, David W. , Newman, Lawrence C. , Lipton, Richard B.
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available